A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by chemist Brian Liau and his collaborators at Harvard offers an ...

Key market opportunities for Cas12 proteins include rising government investments in biotech, increased demand for ...

In many cells of the human body, hair-like protrusions known as cilia act as antennae, allowing cells to receive signals from ...

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Colossal Biosciences expands its de-extinction mission by acquiring Viagen, the world leader in animal cloning and species ...

Gene editing techniques, including CRISPR, prime editing, and nucleases, allow scientists to tackle genetic diseases, cancer, ...

While some practices remain controversial or speculative, biohackers are united by a shared curiosity: how can we engineer ...

Researchers have shown for the first time that flipping an epigenetic “switch” in specific memory-holding neurons can directly alter memory strength.

Our experiences leave traces in the brain, stored in small groups of cells called engrams. Engrams are thought to hold the ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...